Salt suppresses IFNγ inducible chemokines through the IFNγ-JAK1-STAT1 signaling pathway in proximal tubular cells

[1]  A. Nakano,et al.  Salt-Induced Remodeling of Spatially Restricted Clathrin-Independent Endocytic Pathways in Arabidopsis Root , 2015, Plant Cell.

[2]  Matthias Heinig,et al.  Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. , 2015, Cell metabolism.

[3]  J. Ellis,et al.  Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction. , 2015, AJR. American journal of roentgenology.

[4]  S. Sasaki,et al.  Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice. , 2014, Human molecular genetics.

[5]  S. N. Thornton,et al.  Salt in health and disease--a delicate balance. , 2013, The New England journal of medicine.

[6]  W. Weimar,et al.  Differential Effects of Activated Human Renal Epithelial Cells on T-Cell Migration , 2013, PloS one.

[7]  N. Yosef,et al.  Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells , 2013, Nature.

[8]  J. Bonventre,et al.  Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity. , 2013, Biochemical pharmacology.

[9]  A. Regev,et al.  Induction of pathogenic Th17 cells by inducible salt sensing kinase SGK1 , 2013, Nature.

[10]  S. Sasaki,et al.  Phosphorylation of Na-Cl cotransporter by OSR1 and SPAK kinases regulates its ubiquitination. , 2012, Biochemical and biophysical research communications.

[11]  W. B. Reeves,et al.  Endogenous IL-10 Attenuates Cisplatin Nephrotoxicity: Role of Dendritic Cells , 2010, The Journal of Immunology.

[12]  S. Lim,et al.  Interstitial tonicity controls TonEBP expression in the renal medulla. , 2009, Kidney international.

[13]  A. Ortiz,et al.  Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity. , 2009, Kidney international.

[14]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[15]  J. Belperio,et al.  Chemokines and Transplant Vasculopathy , 2008, Circulation research.

[16]  G. Deray,et al.  Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care , 2008, Cancer Chemotherapy and Pharmacology.

[17]  Xueqing Yu,et al.  Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  H. Shibuya,et al.  Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. , 2007, Cell metabolism.

[19]  Amit Singhal,et al.  Modulation of Gamma Interferon Receptor 1 by Mycobacterium tuberculosis: a Potential Immune Response Evasive Mechanism , 2007, Infection and Immunity.

[20]  P. Cristofori,et al.  Renal Proximal Tubule Segment-Specific Nephrotoxicity: An Overview on Biomarkers and Histopathology , 2007, Toxicologic pathology.

[21]  H. Auchincloss,et al.  Role of CXC chemokine receptor 3 pathway in renal ischemic injury. , 2006, Journal of the American Society of Nephrology : JASN.

[22]  Dawood B. Dudekula,et al.  Genome-wide assembly and analysis of alternative transcripts in mouse. , 2005, Genome research.

[23]  P. Romagnani.  From basic science to clinical practice: use of cytokines and chemokines as therapeutic targets in renal diseases. , 2005, Journal of nephrology.

[24]  F. Thaiss,et al.  CXCR3 and CCR5 Positive T-Cell Recruitment in Acute Human Renal Allograft Rejection , 2004, Transplantation.

[25]  C. Cohen,et al.  CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. , 2004, The American journal of pathology.

[26]  E. Blasi,et al.  Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. , 2003, Kidney international.

[27]  R. Coleman,et al.  Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial , 2003, Cancer Chemotherapy and Pharmacology.

[28]  H. Anders,et al.  Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. , 2003, Kidney international.

[29]  P. Cockwell,et al.  Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  Richard J. Johnson,et al.  Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. , 2002, The New England journal of medicine.

[31]  M. Karin,et al.  The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex. , 2001, Molecular cell.

[32]  P. Tipping,et al.  Chemokines as therapeutic targets in renal disease , 2000, Current opinion in nephrology and hypertension.

[33]  P. Subramaniam,et al.  Differential Nuclear Localization of the IFNGR-1 and IFNGR-2 Subunits of the IFN-γ Receptor Complex Following Activation by IFN-γ , 2000 .

[34]  M. Salvadori,et al.  Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. , 1999, Journal of the American Society of Nephrology : JASN.

[35]  A. Luster,et al.  Structure and function of the murine chemokine receptor CXCR3 , 1999, European journal of immunology.

[36]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[37]  James G. Boyd,et al.  Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.

[38]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[39]  K. Murphy,et al.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. , 1996, Journal of immunology.

[40]  J. D'Elia,et al.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.

[41]  T. Cornelison,et al.  Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. , 1993, Gynecologic oncology.

[42]  A. R. Twardock,et al.  Evaluation of a short-term saline diuresis protocol for the administration of cisplatin. , 1988, American journal of veterinary research.

[43]  P. Daley-Yates,et al.  A study of the protective effect of chloride salts on cisplatin nephrotoxicity. , 1985, Biochemical pharmacology.

[44]  Andrew D. Luster,et al.  γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.

[45]  M. Stanier.  The effect of urea loading on volume and concentration of urine in rabbits , 1969, The Journal of physiology.

[46]  R. Riccardi,et al.  The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not? , 2015, Cancer Chemotherapy and Pharmacology.

[47]  Dennis Brown,et al.  Basolateral targeting and microtubule-dependent transcytosis of the aquaporin-2 water channel. , 2013, American journal of physiology. Cell physiology.

[48]  Giuseppe Remuzzi,et al.  Sodium intake, ACE inhibition, and progression to ESRD. , 2012, Journal of the American Society of Nephrology : JASN.

[49]  Laurie J. Pencille,et al.  The Chest Pain Choice Decision Aid: A Randomized Trial , 2012, Circulation. Cardiovascular quality and outcomes.

[50]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[51]  Christopher B Wilson,et al.  Regulation of interferon-gamma during innate and adaptive immune responses. , 2007, Advances in immunology.

[52]  F. Thaiss,et al.  Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. , 2006, Journal of the American Society of Nephrology : JASN.

[53]  P. Taylor,et al.  Stress response inhibits the nephrotoxicity of cisplatin. , 2005, American journal of physiology. Renal physiology.

[54]  P. Subramaniam,et al.  Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[55]  M Aguet,et al.  The IFN gamma receptor: a paradigm for cytokine receptor signaling. , 1997, Annual review of immunology.

[56]  M. Farrar,et al.  The molecular cell biology of interferon-gamma and its receptor. , 1993, Annual review of immunology.